Cardiovascular diseases are a leading cause of death and disability globally, with
inequalities in burden and care delivery evident in Europe. To address this challenge, The …

Atrial fibrillation (AF) significantly increases the risk of stroke and heart failure, but is
frequently asymptomatic and intermittent; therefore, its timely diagnosis poses challenges …

Atrial fibrillation (AF) is a common condition with a global estimated prevalence of 60 million
cases, and the most common cardiac complication of hyperthyroidism, occurring in 5–15 …

The rapid growth of electronic health records (EHRs) has led to unprecedented biomedical
data. Clinician access to the latest patient information can improve the quality of healthcare …

Atrial fibrillation is a major public health problem affecting 37 million people worldwide, 1
and conferring an increased risk of stroke, heart failure, myocardial infarction, and death, as …

Background The incidence of new‐onset atrial fibrillation (NOAF) is increasing in the last
decades. NOAF is associated with worse long‐term prognosis. The C2HEST score has been …

Background The increasing burden of atrial fibrillation (AF) emphasizes the need to identify
high-risk individuals for enrolment in clinical trials of AF screening and primary prevention …

Aims Atrial fibrillation (AF) is the most common type of cardiac arrythmia and is an important
risk factor for ischaemic stroke. Many cases of AF remain undiagnosed due to its …

Abstract Aims The Future Innovations in Novel Detection of Atrial Fibrillation (FIND-AF)
longitudinal cohort study is a multi-centre prospective cohort study of patients identified at …

The increasing prevalence of atrial fibrillation (AF) and its association with Major Adverse
Cardiovascular Events (MACE) presents challenges in early identification and treatment …